Literature DB >> 18298485

MicroRNAs and cancer.

T Dalmay1.   

Abstract

The Nobel Prize in Medicine and Physiology was awarded to the RNA interference (RNAi) field in 2006 because of the huge therapeutic potential this technique harbours. However, the RNAi technology is based on a natural mechanism that utilizes short noncoding RNA molecules (microRNAs) to regulate gene expression. This paper reviews our current knowledge about microRNAs focusing on their involvement in cancer and their potential as diagnostics and therapeutics.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18298485     DOI： 10.1111/j.1365-2796.2008.01926.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN： 0954-6820            Impact factor:   8.989


  45 in total

Review 1.  Molecular pathology and patient care.

Authors:  John D Pfeifer
Journal:  Mo Med       Date:  2010 Mar-Apr

2.  Overexpression of dicer as a result of reduced let-7 MicroRNA levels contributes to increased cell proliferation of oral cancer cells.

Authors:  Andrew Jakymiw; Rushi S Patel; Natasha Deming; Indraneel Bhattacharyya; Priya Shah; Richard J Lamont; Carol M Stewart; Donald M Cohen; Edward K L Chan
Journal:  Genes Chromosomes Cancer       Date:  2010-06       Impact factor: 5.006

Review 3.  Opportunities and challenges facing biomarker development for personalized head and neck cancer treatment.

Authors:  Alexandra Lucs; Benjamin Saltman; Christine H Chung; Bettie M Steinberg; David L Schwartz
Journal:  Head Neck       Date:  2012-01-27       Impact factor: 3.147

4.  Hypoxia-induced microRNA-424 expression in human endothelial cells regulates HIF-α isoforms and promotes angiogenesis.

Authors:  Goutam Ghosh; Indira V Subramanian; Neeta Adhikari; Xiaoxiao Zhang; Hemant P Joshi; David Basi; Y S Chandrashekhar; Jennifer L Hall; Sabita Roy; Yan Zeng; Sundaram Ramakrishnan
Journal:  J Clin Invest       Date:  2010-10-25       Impact factor: 14.808

5.  MiR-34a inhibits oral cancer progression partially by repression of interleukin-6-receptor.

Authors:  Ting Li; Lichu Li; Dongshuang Li; Shuting Wang; Jinhu Sun
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

6.  A systematic analysis of miRNA transcriptome in Marek's disease virus-induced lymphoma reveals novel and differentially expressed miRNAs.

Authors:  Ling Lian; Lujiang Qu; Yanmei Chen; Susan J Lamont; Ning Yang
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

7.  Tumors induced in mice by direct inoculation of plasmid DNA expressing both activated H-ras and c-myc.

Authors:  Li Sheng-Fowler; Fang Cai; Haiqing Fu; Yong Zhu; Brian Orrison; Gideon Foseh; Don G Blair; Stephen H Hughes; John M Coffin; Andrew M Lewis; Keith Peden
Journal:  Int J Biol Sci       Date:  2010-03-29       Impact factor: 6.580

8.  Cardiovascular Disease, Single Nucleotide Polymorphisms; and the Renin Angiotensin System: Is There a MicroRNA Connection?

Authors:  Terry S Elton; Sarah E Sansom; Mickey M Martin
Journal:  Int J Hypertens       Date:  2010-08-04       Impact factor: 2.420

9.  Identification of a novel microRNA cluster miR-193b-365 in multiple myeloma.

Authors:  Kenji Unno; Ying Zhou; Todd Zimmerman; Leonidas C Platanias; Amittha Wickrema
Journal:  Leuk Lymphoma       Date:  2009-11

10.  The inhibition of the highly expressed miR-221 and miR-222 impairs the growth of prostate carcinoma xenografts in mice.

Authors:  Neri Mercatelli; Valeria Coppola; Desirée Bonci; Francesca Miele; Arianna Costantini; Marco Guadagnoli; Elena Bonanno; Giovanni Muto; Giovanni Vanni Frajese; Ruggero De Maria; Luigi Giusto Spagnoli; Maria Giulia Farace; Silvia Anna Ciafrè
Journal:  PLoS One       Date:  2008-12-24       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.